Pilot study of the effects of taprostene (CG 4203) in patients with advanced peripheral arterial disease.

Darius, H

Pilot study of the effects of taprostene (CG 4203) in patients with advanced peripheral arterial disease. [electronic resource] - Progress in clinical and biological research 1989 - 417-21 p. digital

Publication Type: Clinical Trial; Journal Article

0361-7742


Arterial Occlusive Diseases--classification
Blood Pressure--drug effects
Cardiovascular Agents--administration & dosage
Clinical Trials as Topic
Epoprostenol--administration & dosage
Female
Flushing--chemically induced
Humans
Infusions, Intravenous
Male
Platelet Aggregation--drug effects
Prostaglandins, Synthetic--administration & dosage